PTX-100 reduced multiple myeloma tumours AND sensitised multiple myeloma cells in mice models.
Should see buyers return to the stock as the data is presented today at the Cancer Research Meeting.
EV value of $2M is absurd given the trials both pending and underway.
Even at 16c the stock would still be cheap compared to its ASX peers.
Cheers.
.
- Forums
- ASX - By Stock
- PTX
- Ann: Encouraging Pre-Clinical Data Presented at US Cancer Meeting
Ann: Encouraging Pre-Clinical Data Presented at US Cancer Meeting, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.4¢ |
Change
-0.003(6.38%) |
Mkt cap ! $35.43M |
Open | High | Low | Value | Volume |
4.5¢ | 4.6¢ | 4.3¢ | $50.02K | 1.138M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 98999 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 78686 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 98999 | 0.044 |
1 | 249701 | 0.043 |
3 | 145000 | 0.042 |
6 | 477461 | 0.041 |
7 | 247800 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 78686 | 3 |
0.048 | 200000 | 1 |
0.049 | 194091 | 3 |
0.050 | 427445 | 9 |
0.052 | 500000 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |